Common Treatment to Delay Labor Decreases Preterm Infants' Risk for Cerebral PalsyThursday, Aug 28, 2008
Preterm infants born to mothers receiving intravenous magnesium sulfate — a common treatment to delay labor — are less likely
to develop cerebral palsy than are preterm infants whose mothers do not receive it, report researchers in a large National
Institutes of Health research network.
NIH Researchers Find That Rett Syndrome Gene is Full of SurprisesThursday, May 29, 2008
A study funded by the National Institutes of Health (NIH) has transformed scientists' understanding of Rett syndrome, a genetic
disorder that causes autistic behavior and other disabling symptoms. Until now, scientists thought that the gene behind Rett
syndrome was an "off" switch, or repressor, for other genes. But the new study, published today in Science1, shows that it
is an "on" switch for a startlingly large number of genes.
Researchers Develop First Transgenic Monkey Model of Huntington’s DiseaseFriday, May 23, 2008
Scientists have developed the first genetically altered monkey model that replicates some symptoms observed in patients with
Huntington's disease. This advance, reported in Nature, could lead to major breakthroughs in the effort to develop new treatments
for a range of neurological diseases.
NIH to Host Research Symposium on Clinical Applications of Stem Cell TherapiesTuesday, Apr 1, 2008
"Challenges and Promise of Cell-Based Therapies" is a one-day symposium to explore promising research in regenerative medicine
using stem cells.
NIH Announces New Initiative in Epigenomics Tuesday, Jan 22, 2008
NIH Announces New Initiative in Epigenomics
Study Suggests Some Brain Injuries Reduce the Likelihood of Post-Traumatic Stress DisorderSunday, Dec 23, 2007
A new study of combat-exposed Vietnam War veterans shows that those with injuries to certain parts of the brain were less
likely to develop post-traumatic stress disorder (PTSD). The findings, from the National Institutes of Health (NIH) and the
National Naval Medical Center, suggest that drugs or pacemaker-like devices aimed at dampening activity in these brain regions
might be effective treatments for PTSD.
More Press Releases
Qualified media representatives can arrange interviews and photos with NINDS researchers and administrators. E-Mail or call (301) 496-5751.
Office of Communications And Public Liaison
Building 31, Room 8A-07
31 Center Drive MSC 2540
P.O. Box 5801
Bethesda, MD 20824